Canasa and Benicar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Canasa (mesalamine) and Benicar (olmesartan medoxomil). Common drug interactions include alopecia among females and amnesia among males.

The phase IV clinical study analyzes what interactions people have when they take Canasa and Benicar. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Canasa?

Canasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 1,676 Canasa users. Check the latest studies of Canasa.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

On Jul, 12, 2026

18 people who take Canasa and Benicar together, and have interactions are studied.

What are the common drug interactions of Canasa and Benicar, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Anaemia (lack of blood)
Balance disorder
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Influenza like illness
Injection site reaction
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

male:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Ataxia (loss of full control of bodily movements)
Cough
Dental caries
Erectile dysfunction
Influenza like illness
Injection site bruising
Injection site induration
Injection site papule (solid pimple or swelling at injection site)
Injection site reaction

What are the common drug interactions of Canasa and Benicar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Erectile dysfunction
Influenza like illness
Injection site bruising
Injection site erythema (redness at injection site)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Paralysis

60+:

Balance disorder
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anaemia (lack of blood)
Cough
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dental caries
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Injection site erythema (redness at injection site)
Injection site induration

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 16.67%
High Blood Cholesterol: 3 people, 16.67%
Diabetes: 3 people, 16.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 16.67%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 5.56%
Pain: 1 person, 5.56%
Gait Disturbance: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Canasa and Benicar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously